Northridge, CA, Perth, Australia and London, United Kingdom – 25 January 2017 – link here. Avita Medical Ltd (ASX: AVH), (OTCQX: AVMXY), a regenerative medicine company specializing in new treatments for wounds and skin defects, said today that Adam Kelliher, Avita’s Chief Executive Officer, will be a panel member at the Biotech and Money / […]
AB-SA01 meets primary endpoints of safety and tolerability and reduces S. aureus bacterial load in all patients Business update call scheduled for January 4, 2017 at 4:30 p.m. Eastern CATEGORY: Featured Monday, December 19, 2016 8:45 am EST – link here SAN DIEGO EmailPDFPrintRSS PUBLIC COMPANY INFORMATION: NYSEMKT: APHB US03211P1030 “We are delighted with the […]
Business update call scheduled for today at 4:30 p.m. Eastern CATEGORY: Featured Wednesday, January 4, 2017 8:45 am EST – link here SAN DIEGO EmailPDFPrintRSS PUBLIC COMPANY INFORMATION: NYSEMKT: APHB “We saw decreases in S. aureus bacterial load in all patients treated with AB-SA01 in our Phase 1 trial, which is particularly encouraging since most […]